ZOLEDRONIC ACID
Peakzoledronic acid
NDAINTRAVENOUSINJECTABLE
Approved
Aug 2013
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Clinical Trials (5)
Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma
Started Nov 2021
7 enrolled
Leiomyosarcoma
A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis
Started Sep 2020
Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid
Started Jan 2019
0Osteoporosis, Postmenopausal
Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis
Started Mar 2017
61 enrolled
Osteoporosis
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone
Started Dec 2015
11 enrolled
Solitary Osseous Plasmacytoma